Streptokinase, complement activation and hypotension

APMIS

Volumn 105, Issue 8, 1997, Pages 650-654

  Pachaï, Andra ^a,b   Erlendsson, Anne Kiilerich ^a   Brandslund, Ivan ^a  

^a LILLEBAELT HOSPITAL   (Denmark)

^b NONE   (Denmark)

Author keywords

Complement 3d; Hypotension; Myocardial infarction; Streptokinase

Indexed keywords

COMPLEMENT COMPONENT C3; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; DRUG INFUSION; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0030820335     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1997.tb05067.x     Document Type: Article

References (18)

1. A European Collaborative Study: Controlled trial of urokinase in myocardial infarction. Lancet 2: 624-626, 1975.
2. Agostini, A., Gardinali, M., Frangi, D. et al.: Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction. Circulation 90: 2666-2670, 1994.
3. Amsterdam, E. A., Stahl, G. L., Pan, H. L., Rendig, S. V., Fletcher, M. P. & Longhurst, J. C.: Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs. Am. J. Physiol. 268: H 448- H 457, 1995.
4. Brandslund, I., Siersted, H. C., Svehag, S. E. & Teisner, B.: Double-decker rocket immunoelectrophoresis for direct quantitation of complement C3 split products with C3d specificities in plasma. J. Immunol. Methods 44: 63-71, 1981.
5. Brandslund, I., Teisner, B., Petersen, P. H. & Svehag, S. E.: Development and clinical application of electroimmunoassays for the direct quantification of the complement C3 split products C3c and C3d. Scand. J. Clin. Lab. Invest. 44: 57-73, 1984.
6. Ewald, G.A. & Eisenberg, P. R.: Plasmin-mediated activation of contact system in response to pharmacological thrombolysis. Circulation 91: 28-36, 1995.
7. Frangi, D., Gardinali, M., Conciato, L., Cafaro, C., Pozzoni, L. & Agostoni, A.: Abrupt complement activation and transient neutropenia in patients with acute myocardial infarction treated with streptokinase. Circulation 89: 76-80, 1994.
8. Freysdottir, J., Ormarsdottir, S. & Sigfusson, A.: Evaluation of in vivo immune complex formation and complement activation in patients receiving intravenous streptokinase. Clin. Exp. Immunol. 94: 286-290, 1993.
9. Gemmil, J. D., Hogg, K. J., Douglas, J. T. et al.: The incidence and mechanism of hypotension following thrombolytic therapy for acute myocardial infarction with streptokinase-containing agents. Lack of relationship to pretreatment streptokinase resistance. Eur. Heart J. 14: 819- 825, 1993.
10. Hartman, J. C., Wall, T. M., Hullinger, T. G. & Shebuski, K. J.: Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by the bradykinin antagonist HOE 140. J. Cardiovasc. Pharmacol. 21: 996-1003, 1993.
11. Lew, A. S., Laramee, P., Cercek, B., Shah, P. K. & Ganz, W.: The hypotensive effect of intravenous streptokinase in patients with acute myocardial infarction. Circulation 72: 1321-1326, 1985.
12. McManus, L. M., Kolb, W. P., Crawford, M. H., O'Rourke, R. A., Grover, F. L. & Pinckard, R. N.: Complement localization in ischemic baboon myocardium. Lab. Invest. 48: 436-447, 1983.
13. Munkvad, S., Brandslund, I., Gram, J. & Jespersen, J.: The complement system is activated by streptokinase, but not by combined heparin-recombinant tissue-type plasminogen activator therapy in patients with myocardial infarction: a placebo-controlled study. Coron. Artery Dis. 2: 889-895, 1991.
14. Noda, K., Sasaguri, M., Ideishi, M., Ikeda, M. & Arakawa, K.: Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs. Cardiovasc. Res. 27: 334- 340, 1993.
15. Pinchard, R. N., O'Rourke, R. A., Crawford, M. H. et al.: Complement localization and mediation of ischemic injury in baboon myocardium. J. Clin. Invest. 66: 1050-1056, 1980.
16. Schäfer, H., Mathey, D., Hugo, F. & Bhakdi, S.: Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. J. Immunol. 137: 1945-1949, 1986.
17. Väkevä, A., Morgan, B. P., Tikkanen, I., Helin, K., Laurila, P. & Meri, S.: Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium. Am. J. Pathol. 144: 1357-1368, 1994.
18. Verstraete, M., Bory, M., Collen, D. et al.: Randomized trial of intravenous recombinant tissue- type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for recombinant tissue-type plasminogen activator. Lancet 1: 842-847, 1985.